Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of HIP1402 in Healthy Male Volunteers
NCT02529800Phase 1Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Sep 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of tamsulosin in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Hanmi Pharmaceutical. Primary endpoints: Area Under the Curve, Maximum Plasma Concentration and 4 more. Started Sep 2015; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02529800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02529800.